USA Financial Formulas’s NOV NOV Stock Holding History

USA Financial Formulas’s Portfolio NOV Stock Details NOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-32	Closed	-$592	–	502
2023 Q1	$592	Buy	+32	New	+$691	﹤0.01%	345
2022 Q3	$0	Buy	+24	New	+$404	﹤0.01%	377

Other funds holding NOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

USA Financial Formulas's NOV Position: Q2 2023 in Review

USA Financial Formulas sold out of NOV (NOV) in Q2 2023, closing a stake of 32 shares — an estimated $592 sold.

USA Financial Formulas first reported a position in NOV in Q3 2022 and held it in 2 quarters. The position peaked at $592 in Q1 2023. 366 funds tracked by Wall St. Rank hold NOV as of Q2 2023.

USA Financial Formulas reported no remaining NOV position as of Q2 2023 after selling out during the quarter.
USA Financial Formulas sold 32 NOV shares in Q2 2023, an estimated $592.
USA Financial Formulas first reported a position in NOV in Q3 2022 and held it in 2 quarters.
USA Financial Formulas's NOV position peaked at $592 in Q1 2023.
366 funds tracked by Wall St. Rank held NOV as of Q2 2023.

Based on USA Financial Formulas's 13F filing for Q2 2023, filed 27 Nov 2023.